They have to consider many factors including cost and that probably effects the waiting time for answers, who gets treatment with what drugs. (my opinion) Someone with geno 3 was trying to decide on a phase 3 trial wondered why they were getting SOF + PR (12) instead of SOF + R (24) so I only provided an example of a couple of cost charts.